Over the past year there were no insider purchases at Prestige Consumer Healthcare Inc.. Two insiders sold roughly $424,000 instead.
Selling on its own is common and often pre-planned (10b5-1 plans, taxes, diversification), so it matters more when it is unusually heavy or broad.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | Zerillo Jeffrey | Officer | Sell | 351 | $52.28 | $18K | SEC |
| May 11, 2026 | Zerillo Jeffrey | Officer | Sell | 305 | $54.36 | $17K | SEC |
| May 7, 2026 | Zerillo Jeffrey | Officer | Sell | 1,207 | $54.99 | $66K | SEC |
| May 6, 2026 | Zerillo Jeffrey | Officer | Sell | 346 | $55.32 | $19K | SEC |
| Feb 13, 2026 | Zerillo Jeffrey | Officer | Sell | 1,000 | $65.93 | $66K | SEC |
| Dec 2, 2025 | Zerillo Jeffrey | Officer | Sell | 719 | $60.00 | $43K | SEC |
| Dec 2, 2025 | Zerillo Jeffrey | Officer | Sell | 281 | $60.00 | $17K | SEC |
| Nov 26, 2025 | BYOM JOHN E | Director | Sell | 3,000 | $59.35 | $178K | SEC |
| Mar 12, 2025 | Fritz Mary Beth | Executive Officer | Sell | 1,678 | $90.00 | $151K | SEC |
| Mar 5, 2025 | Fritz Mary Beth | Executive Officer | Sell | 6,297 | $85.39 | $538K | SEC |
| Feb 13, 2025 | Mekhail Adel | Executive Officer | Sell | 5,683 | $86.30 | $490K | SEC |
| Feb 13, 2025 | Mekhail Adel | Executive Officer | Sell | 5,400 | $86.82 | $469K | SEC |
| Nov 21, 2024 | Lombardi Ronald M. | CEO | Sell | 5,213 | $82.55 | $430K | SEC |
| Nov 21, 2024 | Lombardi Ronald M. | CEO | Sell | 5,662 | $82.64 | $468K | SEC |
| Nov 19, 2024 | Lombardi Ronald M. | CEO | Sell | 48,512 | $82.67 | $4.0M | SEC |
In the last 12 months Prestige Consumer Healthcare Inc. insiders made open-market purchases worth about $0 and sales worth about $424,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in PBH was filed on 2026-05-12.
No congressional trades in PBH were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).